Specific targeting of IL-1β activity to CD8(+) T cells allows for safe use as a vaccine adjuvant.
- DOI
- 10.1038/s41541-020-00211-5
- Published
- 2020
- Container
- NPJ vaccines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41541-020-00211-5,
title = {Specific targeting of IL-1β activity to CD8(+) T cells allows for safe use as a vaccine adjuvant.},
author = {Van Den Eeckhout B and Van Hoecke L and Burg E and Van Lint S and Peelman F and Kley N and Uzé G and Saelens X and Tavernier J and Gerlo S},
year = {2020},
journal = {NPJ vaccines},
doi = {10.1038/s41541-020-00211-5},
url = {https://doi.org/10.1038/s41541-020-00211-5}
}RIS
TY - JOUR TI - Specific targeting of IL-1β activity to CD8(+) T cells allows for safe use as a vaccine adjuvant. AU - Van Den Eeckhout B AU - Van Hoecke L AU - Burg E AU - Van Lint S AU - Peelman F AU - Kley N AU - Uzé G AU - Saelens X AU - Tavernier J AU - Gerlo S PY - 2020 JO - NPJ vaccines DO - 10.1038/s41541-020-00211-5 UR - https://doi.org/10.1038/s41541-020-00211-5 ER -
APA
B, V. D. E., L, V. H., E, B., S, V. L., F, P., N, K., G, U., X, S., J, T., & S, G. (2020). Specific targeting of IL-1β activity to CD8(+) T cells allows for safe use as a vaccine adjuvant.. NPJ vaccines. https://doi.org/10.1038/s41541-020-00211-5
Source records
- pubmed · retrieved 2026-11-10T13:20:51.268Z